Suggestions
Ken Walsh
Ken Walsh is a Partner with Clarivate Consulting, specializing in Access & Commercialization.12 He brings over 20 years of experience in the life science industry, with a particular focus on global pricing and market access strategy.1
Professional Background
Ken's expertise spans various areas within the life sciences sector:
- Clinical trial design strategy for Health Technology Assessments (HTAs)
- Business Development and Licensing (BD&L) assessments and landscape analysis
- MedTech reimbursement strategy and tactics
- Pricing strategy and tactical tools/modeling
- Mock Negotiation Workshops and stakeholder engagement1
Prior to his role at Clarivate, Ken held significant industry positions:
- Head of pricing in GSK's emerging markets division
- Global head of pricing and market access for Sandoz Biosimilars and Oncology injectables business unit1
Education
Ken's academic background includes:
- MA (Hons) in Economics from Heriot-Watt University
- MSc in Finance from Cass Business School, London14
Current Role and Responsibilities
At Clarivate, Ken leads engagements that span from development to commercial strategy, with a particular emphasis on Europe and emerging markets.1 He is actively involved in giving presentations at international conferences on various market access and public policy issues.1
Ken is based in London, England, United Kingdom.35 His LinkedIn profile can be found under the username ken-walsh-b0b2862, where he has over 500 connections.3